Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Telomir Pharmaceuticals Inc (TELO)

Telomir Pharmaceuticals Inc (TELO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price ACCESSWIRE - Thu Dec 12, 2:30AM CST

Transaction follows a $5 million non-dilutive credit line from the same trusted partner, further reinforcing Telomir's financial strength and growth potential.

TELO : 5.20 (+2.16%)
Image by Halfpoint via Shutterstock
Telomir Pharmaceuticals Achieves Breakthrough in Type 2 Diabetes Treatment with Novel Age-Reversal Drug Barchart Impact - Tue Dec 3, 8:04AM CST

Telomir Pharmaceuticals has made a significant breakthrough in diabetes research, demonstrating that their novel compound, Telomir-1, can reverse key parameters of Type 2 diabetes by addressi

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1 ACCESSWIRE - Tue Dec 3, 1:30AM CST

Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root, achieving reversal to near pre-diabetic levels...

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals
Telomir Pharmaceuticals' Breakthrough Study Reveals Major Age-Reversal Results in Advanced Preclinical Testing Barchart Impact - Thu Nov 21, 7:18AM CST

Telomir Pharmaceuticals has made a significant breakthrough in longevity science with Telomir-1, a compound that demonstrates remarkable age-reversal effects, including extended lifespan, imp

TELO : 5.20 (+2.16%)
Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1 ACCESSWIRE - Thu Nov 21, 1:00AM CST

MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader in age-reversal science, today announced groundbreaking preclinical...

TELO : 5.20 (+2.16%)
PR images (don't use) - Telomir Pharmaceuticals, Inc_
Telomir Pharmaceuticals' Age Reversal Pill Shows Promise in Canine Study Barchart Impact - Wed Sep 4, 7:00AM CDT

A recent ABC exclusive highlighted Telomir Pharmaceuticals' "age reversal" pill, showing remarkable results in two senior dogs. The company's innovative approach to longevity science has spar

TELO : 5.20 (+2.16%)
PR images (don't use) - Telomir
Discover the Future of Youthfulness with Telomir Pharmaceuticals' Breakthrough Technology Barchart Impact - Wed May 15, 5:36PM CDT

Telomir Pharmaceuticals is a pharmaceutical company whose main focus is on the development and commercialization of Telomir-1.

TELO : 5.20 (+2.16%)

Barchart Exclusives

How to Profitably Exploit a Temporary Sentiment Reversal in Planet Labs (PL) Barchart - Sat Dec 14, 9:15AM CST
While PL stock has been one of the surprise winners this year, a corrective lull isn’t out of the question. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot